| 000 | 01291 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514164537.0 | ||
| 264 | 0 | _c20040113 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a1359-6446 | ||
| 024 | 7 |
_a10.1016/s1359-6446(03)02919-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHooft, Rob | |
| 245 | 0 | 0 |
_aDrug discovery and development for metabolic diseases. _h[electronic resource] |
| 260 |
_bDrug discovery today _cDec 2003 |
||
| 300 |
_a1064-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAppetite _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCongresses as Topic |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aGlucagon _xtherapeutic use |
| 650 | 0 | 4 | _aGlucagon-Like Peptide 1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 |
_aPeptide Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aPeptide YY _xpharmacology |
| 650 | 0 | 4 |
_aPharmacology, Clinical _xtrends |
| 650 | 0 | 4 |
_aProtein Precursors _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Glucocorticoid _xantagonists & inhibitors |
| 773 | 0 |
_tDrug discovery today _gvol. 8 _gno. 23 _gp. 1064-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1359-6446(03)02919-2 _zAvailable from publisher's website |
| 999 |
_c14424341 _d14424341 |
||